Published
2799a HAE
Notice number: 00588716-2026
KEY INFORMATION
- Submission deadline
- • Oct 1, 2026
- Location
- 🇳🇴 Norway
- Contracting authority
- Sykehusinnkjøp hf
- Accepted Languages
- Norwegian
- Tender type
- Goods
- Contract Value
- Published date
- Aug 26, 2026
TENDER DESCRIPTION
The contracting authority for this competition is Sykehusinnkjøp HF, on behalf of the four regional health authorities in Norway: Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF and Helse Nord RHF. The contracting authority shall, on behalf of the four regional health authorities in Norway enter into framework agreements for the procurement of medicines with active ingredient for heriditarian angioedema (HAE) disease. The procurement includes the following ATC groups: B06AC01 - C1 inhibitor B06AC02 - Ikatibant B06AC04 - Konestat alfa B06AC05 - Lanadelumab B06AC06 - Beroltral state B06AC07 - Garadacimab B06AC08 - Sebetral state B06AC09 - Donidalorsen See Annex 3 Requirement Specifications and The Competition Provisions for detailed information.
TENDER BRIEF
Login to view all answers and insights
Unlock tender brief for freeTENDER DOCUMENTS
DIRECTORY • 3 FILES
- Submission PortalLINK
- non-restricted-documentLINK
- TED PortalLINK
Login to view and download all tender documents
Unlock documents for freeASK AI ABOUT THIS TENDER
Can a foreign company apply?
Yes, foreign companies can apply as long as they meet all the requirements set out in the procurement documents.
Login to ask more questions.
Unlock AI tender chat for freeUnlock your tender workflow
Run your first search, evaluate the results, save a daily monitor and start building a pipeline of tenders worth pursuing.